Sunday, 24 March 2019

BioTech News

  • WuXi, OMT join hands to develop OmniRat antibodies

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US, and Open Monoclonal Technol...Read more

  • Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

  • A*STAR Scientists Discover Potential Drug for Deadly Brain Cancer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults - glioblastoma multiforme. The scientists found that by targeting this biomarker...Read more

  • Early Hep B treatment effective in clearing virus

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London, have discovered that children and young patients with...Read more

  • Indo-Aussie research to find ovarian cancer cure

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • Japan scientists pioneer new stem cell technology

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • joimax goes BRIC and beyond

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more

  • NIH develops groundbreaking dengue vaccine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jan, 2013

    Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has generated a strong immune response. The early-stage clinical trial wa...Read more

  • Malvern acquires nanoparticle firm NanoSight

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: UK-based Malvern Instruments, a leading global provider of instrumentation and expertise for materials and biophysical characterization, has acquired nanoparticle characterizatio...Read more

  • Ambrx partners with WuXi to advance breast cancer treatement

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: In an effort to advance its breast cancer treatment, Ambrx has now partnered with WuXi PharmaTech and a Chinese drugmaker. As per the deal, Ambrx and Zhejiang Medicine will co-d...Read more

  • Thermo Fisher opens new facility in China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Thermo Fisher Scientific, the world leader in serving science, announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consum...Read more

  • Arno finds way to identify breast cancer receptor

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Arno Therapeutics, a US-based clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, has identified a new immunohistochemistry technique fo...Read more

  • Trial begins for vaccine that builds gluten tolerance

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

  • Skin cancer promoting gene discovered

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2012

    Singapore: Researchers from the University of Zurich have discovered a gene that plays a central role in black skin cancer or melanoma. Suppressing this gene in mice inhibits the developmen...Read more

  • Report: Taiwan is 3rd best country to invest in the world

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: Taiwan stands second in the ranking of best investment environment in Asia and third in the world racing behind Singapore and Switzerland, according to a report titled 'Evaluatio...Read more

  • Scientists discover childhood epilepsy genes

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: National Institute of Health (NIH)-funded genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying ...Read more

  • Taiwan boosts medtech and R&D

    BioTech |  Analysis | By Piyusha Chatterjee | 0 Comment | 24 May, 2012

    An ideal location to enter the huge China market and other markets of Asia Pacific region, is Taiwan which is poised for good growth in the bioscience industry. The country is expected to p...Read more

  • India lags behind neighbors on key health measures

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Bangalore: Indians are living longer lives, but illness and disability of a very high order and relatively early death remain severe health care challenges. What should cause concern to he...Read more

Podcast

 

Survey Box

Are policy innovations key to address the healthcare challenges in Asia?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls